# Atrial Fibrillation in Relationship to Plasma Biomarkers

> **NCT04710745** · — · UNKNOWN · sponsor: **Premedix Academy** · enrollment: 300 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DIAGNOSTIC_TEST:** Peripheral blood samples for routine analysis including NT-proBNP and plasmatic biomarkers.
- **DIAGNOSTIC_TEST:** Echocardiography
- **DIAGNOSTIC_TEST:** ECG Holter monitor
- **DIAGNOSTIC_TEST:** Standardized Mini-Mental Status Exam (SMMSE)

## Key facts

- **NCT ID:** NCT04710745
- **Lead sponsor:** Premedix Academy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-04
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04710745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04710745, "Atrial Fibrillation in Relationship to Plasma Biomarkers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04710745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*